Jennifer Marchand, NP
Family · Port Barre, LANPI 1952868051
Payments from drug & device makers
Across 210 payments — averaging $19.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$1K
- Sanofi$527
- Regeneron Healthcare Solutions, Inc.$402
- Lilly USA, LLC$382
- Galderma Laboratories, L.p.$279
- AbbVie$274
- plus $1K from 19 others
What the payments were for
- Food & beverage$3,70988%
- Education$48612%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson(2 entities) | 48 | $1,210 |
| Sanofi | 23 | $527 |
| Regeneron Healthcare Solutions, Inc. | 19 | $402 |
| Lilly USA, LLC | 27 | $382 |
| Galderma Laboratories, L.p. | 21 | $279 |
| AbbVie | 17 | $274 |
| UCB, Inc. | 14 | $230 |
| LEO Pharma Inc. | 7 | $135 |
| Sun Pharmaceutical Industries Inc. | 3 | $117 |
| Amgen | 5 | $96 |
| Pfizer | 3 | $70 |
| Mayne Pharma Commercial LLC | 2 | $53 |
| Botanix SB Inc | 3 | $50 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $49 |
| Dermavant Sciences, Inc. | 2 | $47 |
| Incyte Corporation | 2 | $43 |
| Almirall LLC | 2 | $37 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 2 | $37 |
| Novartis | 2 | $33 |
| Verrica Pharmaceuticals Inc. | 1 | $33 |
| Biowound Solutions, Inc. | 1 | $29 |
| Arcutis Biotherapeutics, Inc. | 1 | $20 |
| Journey Medical Corporation | 1 | $16 |
| Organon | 1 | $15 |
| Medimetriks Pharmaceuticals, Inc. | 1 | $14 |
How this compares
$4,195 in reported general payments places this provider in the 85th percentile of 3,610 family providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clobetasol Propionate | 80 | $3,629 |
| Tacrolimus | 15 | $2,840 |
| Ketoconazole | 107 | $2,096 |
| Metronidazole | 18 | $1,493 |
| Fluorouracil | 23 | $1,466 |
| Triamcinolone Acetonide | 115 | $1,092 |
| Mupirocin | 99 | $725 |
| Fluconazole | 54 | $591 |
| Doxycycline Hyclate | 55 | $426 |
| Hydrocortisone | 27 | $269 |
| Nystatin | 11 | $144 |
| Prednisone | 18 | $47 |
Paid to pharmacies, not to this prescriber.
Other family in Port Barre
- Rebecca EzellSlidell$268K
- Erin PierceNew Orleans$261K
- Tavell KindallNew Orleans$194K
- Ashlea HillRuston$169K
- Brittany MillerVille Platte$158K
- Ryanne ClarkeGretna$123K
- Elidia DewittBaton Rouge$108K
- Rebekah GarrardLafayette$105K
- Tiffany RoeShreveport$97K
- Ghenet GhebretatiosBaton Rouge$91K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.